CAPTRUST Financial Advisors’s NovoCure NVCR Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$195K	Buy	17,874 +7,228	+68%	+$90.3K	﹤0.01%	2693
2025 Q4	$138K	Buy	+10,646	New	+$137K	﹤0.01%	2580
2022 Q3	–	Sell	-1,239	Closed	-$86K	–	3353
2022 Q2	$86K	Buy	1,239 +360	+41%	+$27.1K	﹤0.01%	2324
2022 Q1	$73K	Buy	879 +126	+17%	+$9.28K	﹤0.01%	2506
2021 Q4	$57K	Sell	753 -10	-1%	-$1K	﹤0.01%	2570
2021 Q3	$89K	Sell	763 -442	-37%	-$66.8K	﹤0.01%	2163
2021 Q2	$267K	Buy	1,205 +851	+240%	+$166K	﹤0.01%	1337
2021 Q1	$47K	Buy	354 +269	+316%	+$42.6K	﹤0.01%	2463
2020 Q4	$15K	Hold	85	–	–	﹤0.01%	2396
2020 Q3	$10K	Sell	85 -143	-63%	-$11.4K	﹤0.01%	2281
2020 Q2	$14K	Buy	+228	New	+$15K	﹤0.01%	2069
2019 Q4	–	Sell	-516	Closed	-$39K	–	1521
2019 Q3	$39K	Buy	516 +150	+41%	+$12K	﹤0.01%	1074
2019 Q2	$23K	Buy	+366	New	+$18.5K	﹤0.01%	1243

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

CAPTRUST Financial Advisors's NVCR Position: Q1 2026 in Review

CAPTRUST Financial Advisors increased its NovoCure (NVCR) stake by 68% in Q1 2026, buying an estimated $90.3K and bringing the position to 17,874 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #2693.

CAPTRUST Financial Advisors first reported a position in NVCR in Q2 2019 and has held it in 13 quarters since. The position peaked at $267K in Q2 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

CAPTRUST Financial Advisors held 17,874 shares of NovoCure worth $195K as of Q1 2026.
CAPTRUST Financial Advisors bought 7,228 NovoCure shares in Q1 2026, an estimated $90.3K.
NovoCure made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2693 holding.
CAPTRUST Financial Advisors first reported a position in NovoCure in Q2 2019 and has held it in 13 quarters since.
CAPTRUST Financial Advisors's NovoCure position peaked at $267K in Q2 2021.
222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.